Your browser is no longer supported. Please, upgrade your browser.
Settings
AGN Allergan plc daily Stock Chart
AGN [NYSE]
Allergan plc
IndexS&P 500 P/E- EPS (ttm)-0.58 Insider Own0.28% Shs Outstand345.01M Perf Week-7.01%
Market Cap54.41B Forward P/E9.64 EPS next Y16.36 Insider Trans-1.38% Shs Float336.15M Perf Month-16.10%
Income-205.90M PEG- EPS next Q4.11 Inst Own88.50% Short Float0.80% Perf Quarter-14.38%
Sales16.03B P/S3.39 EPS this Y-543.10% Inst Trans0.79% Short Ratio1.33 Perf Half Y-1.57%
Book/sh207.99 P/B0.76 EPS next Y-0.85% ROA2.00% Target Price209.44 Perf Year-8.21%
Cash/sh3.51 P/C44.97 EPS next 5Y6.00% ROE3.10% 52W Range142.81 - 197.00 Perf YTD-3.58%
Dividend2.88 P/FCF9.97 EPS past 5Y7.18% ROI-2.10% 52W High-19.94% Beta1.31
Dividend %1.83% Quick Ratio0.80 Sales past 5Y21.90% Gross Margin86.40% 52W Low10.44% ATR5.28
Employees17800 Current Ratio0.90 Sales Q/Q-3.00% Oper. Margin16.30% RSI (14)30.63 Volatility2.45% 3.30%
OptionableYes Debt/Eq0.33 EPS Q/Q99.10% Profit Margin13.80% Rel Volume1.52 Prev Close162.65
ShortableYes LT Debt/Eq0.32 EarningsOct 30 BMO Payout42.60% Avg Volume2.03M Price157.72
Recom2.00 SMA20-8.90% SMA50-13.69% SMA200-7.84% Volume3,057,533 Change-3.03%
Oct-09-18Resumed Guggenheim Buy
Apr-24-18Resumed Citigroup Buy $200
Apr-23-18Resumed Evercore ISI Outperform
Apr-17-18Initiated Stifel Hold $192
Feb-23-18Initiated SunTrust Buy $200
Feb-07-18Reiterated Leerink Partners Outperform $237 → $242
Dec-07-17Downgrade Argus Buy → Hold
Nov-29-17Upgrade Morgan Stanley Equal-Weight → Overweight
Nov-27-17Resumed Leerink Partners Outperform $237
Nov-02-17Reiterated RBC Capital Mkts Outperform $250 → $221
Oct-19-17Reiterated RBC Capital Mkts Outperform $277 → $250
Oct-17-17Reiterated UBS Buy $275 → $255
Oct-02-17Reiterated Barclays Equal Weight
Sep-25-17Reiterated RBC Capital Mkts Outperform $285 → $277
Sep-20-17Downgrade Morgan Stanley Overweight → Equal-Weight
Jun-16-17Initiated Cantor Fitzgerald Neutral $231
Jun-09-17Reiterated Mizuho Buy $275 → $267
May-10-17Reiterated RBC Capital Mkts Outperform $279 → $284
May-10-17Downgrade Goldman Buy → Neutral
Feb-09-17Reiterated Mizuho Buy $273 → $275
Nov-12-18 01:18PM  Final trades: Allergan, Verizon, JPMorgan, Visa & Yelp CNBC Videos
Nov-09-18 05:47PM  Edited Transcript of AGN earnings conference call or presentation 30-Oct-18 12:30pm GMT Thomson Reuters StreetEvents
11:02AM  6 Pharmaceutical Stocks to Buy After the Midterms InvestorPlace
Nov-08-18 09:56AM  Ironwood (IRWD) Q3 Earnings & Revenues Miss, Shares Down Zacks
08:00AM  Editas Medicine Makes Steady Progress in Another Solid Quarter Motley Fool
06:11AM  Allergan Funding SCS -- Moody's assigns Baa3 to Allergan's notes; stable outlook Moody's
Nov-07-18 07:37PM  Editas Medicine, Inc. (EDIT) Q3 2018 Earnings Conference Call Transcript Motley Fool
Nov-05-18 08:00AM  Allergan to Present at Credit Suisse 27th Annual Healthcare Conference PR Newswire
Nov-04-18 08:34AM  4 Days Left Before Allergan plc (NYSE:AGN) Will Be Trading Ex-Dividend, Simply Wall St.
Nov-02-18 05:07PM  Ride the Wellness Wave at Sea with Shares of this Unique Spa Operator IPO Edge
11:41AM  Drug Stocks to Post Earnings on Nov 5: MYL, NBIX, RARE, TARO Zacks
09:53AM  Teva (TEVA) Q3 Earnings Beat, 2018 EPS View Up, Shares Rise Zacks
09:12AM  Allergan Needs to Rebase on the Charts - Don't Rush It TheStreet.com
08:09AM  Pharma Stock Roundup: PFE, AGN Q3 Earnings, LLY, NVS Collaboration Deals in Focus Zacks
Nov-01-18 08:45PM  A One-Two Punch to the Bears: Cramer's 'Mad Money' Recap (Thursday 11/1/18) TheStreet.com
07:23PM  Drug stocks 'no longer' safety nets for investors CNBC Videos
07:01PM  Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken TheStreet.com
06:44PM  Drug stocks are 'no longer' reliable safety nets for inve... CNBC Videos
06:27PM  Drug stocks are 'no longer' reliable safety nets for investors: Cramer CNBC
12:13PM  Does Allergan plcs (NYSE:AGN) CEO Pay Compare Well With Peers? Simply Wall St.
09:41AM  Pfizer weighing sale of women's health portfolio - Bloomberg Reuters
09:38AM  ICR Hires BlackRock Executive to Lead Governance Advisory Solutions Group CorpGov.com
Oct-31-18 05:48PM  Jerome Dodson Comments on Allergan GuruFocus.com
12:11PM  Trippy depression treatment? Hopes and hype for ketamine Associated Press
11:23AM  Is a Beat in Store for Editas (EDIT) This Earnings Season? Zacks
Oct-30-18 01:47PM  US Stock Market Rises Tuesday GuruFocus.com -7.55%
01:41PM  Pharma's support of Trump's drug pricing plan is fraying heading into midterms CNBC
01:23PM  Allergan Finance, LLC -- Moody's: Allergan's debt reduction credit positive Moody's
01:18PM  Allergan PLC (AGN) Q3 2018 Earnings Conference Call Transcript Motley Fool
11:09AM  Allergan says offers undervalue business units for sale, shares fall Reuters
11:09AM  Allergan says offers undervalue business units for sale, shares fall Reuters
10:51AM  Allergan (AGN) Beats on Q3 Earnings, Raises 2018 Guidance Zacks
10:44AM  Allergan CEO on expanding Botox to millennial and Trump's... CNBC Videos
09:45AM  Allergan CEO disappointed with early buyer interest in business units Reuters
09:42AM  Allergan Earnings, Revenue beat in Q3 Investing.com
09:23AM  Allergan Shares Fall Despite Q3 Beat, Increased Guidance TheStreet.com
08:29AM  Botox sales power Allergan's profit beat, forecast raise Reuters
08:20AM  Botox sales power Allergan's profit beat, forecast raise Reuters
08:00AM  Allergan (AGN) Tops Q3 Earnings and Revenue Estimates Zacks
07:29AM  Allergan: 3Q Earnings Snapshot Associated Press
07:28AM  Allergan reports Q3 beats alongside net loss MarketWatch
06:53AM  Allergan narrows loss in latest quarter but widens full-year loss forecast MarketWatch
06:42AM  Botox-maker Allergan's revenue drops 3 pct Reuters
06:30AM  Allergan Reports Third Quarter 2018 Results Including GAAP Net Revenues of $3.9 Billion PR Newswire
Oct-29-18 02:16PM  Allergan's Q3 Earnings Outlook Benzinga
10:17AM  Health Care Digest: A small biotech goes head first, Gilead's lower tax rate and more American City Business Journals
09:02AM  The Zacks Analyst Blog Highlights: Allergan, Regeneron Pharmaceuticals, Amgen, Alnylam Pharmaceuticals and AMAG Pharmaceuticals Zacks
02:23AM  Novartis, Pfizer join forces on potentially lucrative fatty liver disease Reuters
02:15AM  Novartis, Pfizer join forces on potentially lucrative fatty liver disease Reuters
Oct-27-18 04:40PM  Stocks That Fell to 3-Year Lows in the Week of Oct. 26 GuruFocus.com
Oct-26-18 04:02PM  5 Drug/Biotech Stocks Likely to Beat Estimates in Q3 Earnings Zacks
07:30AM  Allergan Declares Fourth Quarter 2018 Cash Dividend of $0.72 Per Ordinary Share PR Newswire
Oct-24-18 11:23AM  Is a Beat in the Cards for Allergan (AGN) in Q3 Earnings? Zacks
Oct-23-18 10:32AM  Allergan (AGN) Q3 Earnings Preview: What's in the Cards? Zacks
07:30AM  CoolSculpting® And Kristin Davis Partner To Overcome Denim Denial Blues PR Newswire
Oct-22-18 10:01AM  Allergan and The Allergan Foundation Support U.S. Veterans With "Heroes MAKE America" Sponsorship PR Newswire
07:50AM  Report: Exploring Fundamental Drivers Behind Adobe, Allergan plc, Netflix, Wyndham Worldwide, Genuine Parts, and Analog Devices New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Oct-19-18 10:05AM  Ironwood Rides on Linzess' Progress, Stalls Lenisurad Drugs Zacks
07:30AM  Allergan to Showcase Continued Eye Care Innovation with New Data on Investigational Medicines at the American Academy of Ophthalmology Annual Meeting PR Newswire
Oct-17-18 09:40AM  Can Allergan's Key Drugs, Solid Pipeline Abate Generic Woes? Zacks
07:44AM  Allergan plans to file for U.S. approval of new migraine drug by Q1 of 2019 MarketWatch
07:30AM  Allergan Announces Completion of Two Positive Safety Studies for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine PR Newswire
06:00AM  5 Blue Chip Drug Stocks Poised for Long-Term Gains Investopedia
Oct-16-18 09:00AM  FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years PR Newswire
Oct-11-18 04:15PM  Allergan To Present Data From 13 Abstracts At The 2018 American Society For Dermatologic Surgery Meeting In Phoenix PR Newswire
Oct-09-18 04:35PM  Better Buy: Crispr Therapeutics AG vs. Editas Motley Fool
Oct-08-18 08:00AM  Allergan Presents New Research at the American College of Gastroenterology Annual Scientific Meeting (ACG 2018) PR Newswire
Oct-05-18 07:30AM  Allergan Launches Personalized Study Approach for Clinical Research Programs in Inflammatory Bowel Disease PR Newswire
Oct-04-18 07:30AM  Allergan Receives FDA Clearance To Treat Area Below The Jawline With CoolSculpting® PR Newswire
Oct-03-18 10:37AM  Paratek (PRTK) Gets FDA Approval for Nuzyra and Seysara Zacks
08:29AM  Health care just posted its best quarter in 5 years, but there's still value to be found says trader CNBC
07:45AM  Allergan Launches New JUVÉDERM® IT Campaign Designed To Reach The Next Generation Of Consumers PR Newswire
Oct-01-18 05:30PM  Genentech's first scientist now focused on Bay Area's latest biotech IPO American City Business Journals
08:00AM  Allergan to Report Third Quarter 2018 Earnings and Host Conference Call and Webcast PR Newswire
Sep-28-18 10:07AM  Pharma Stock Roundup: PFE, LLY Get Approval for New Drugs, Novartis to Cut Jobs Zacks
07:30AM  Allergan And The Allergan Foundation Support Breast Cancer Patients With New Charitable Programs PR Newswire
Sep-27-18 03:10PM  Allergan Eyes Vraylar Label Expansion, FDA Accepts sNDA Zacks
Sep-26-18 07:30AM  Allergan Announces FDA Acceptance of Supplemental New Drug Application For VRAYLAR® (cariprazine) PR Newswire
Sep-21-18 01:56PM  4 Stocks John Paulson and Paul Tudor Jones Agree On GuruFocus.com
11:22AM  Why an Exton pharma firm will benefit from Almirall's $550M deal with Allergan American City Business Journals
10:21AM  3 Drug/Biotech Stocks in Focus on World Alzheimer's Day Zacks
Sep-20-18 07:10PM  [$$] Gormley's Take: Future of Aesthetic Medicine Not Just Another Pretty Face The Wall Street Journal
07:30AM  Allergan Teams Up with Actor Scott Eastwood to Encourage Recognition of World Alzheimer's Day on September 21st PR Newswire
Sep-19-18 08:53AM  Allergan Announces Plans to Build First Medical Aesthetics Innovation Center in Chengdu China PR Newswire
01:05AM  Teva Wins Approval From FDA for Blockbuster Migraine Drug InvestorPlace
Sep-17-18 04:11PM  JMP: Changing Competitive Landscape Makes Revance Less Appealing Benzinga
10:38AM  Allergan Frown Lines Study Passes Test on Higher Botox Dose Zacks
Sep-14-18 04:15PM  Allergan Announces Results of Higher Dose BOTOX® Cosmetic (onabotulinumtoxinA) for the Treatment of Moderate to Severe Glabellar Lines PR Newswire
03:25PM  FDA plans meeting to discuss safety data on breast implants Associated Press
03:00PM  Allergan Highlights Key Growth Drivers for Medical Aesthetics PR Newswire
01:49PM  Allergan says revenue from aesthetics unit may double by 2025 Reuters
12:55PM  [$$] The Curious New Botox Ads The Wall Street Journal
12:08PM  Who Really Owns Allergan plc (NYSE:AGN)? Simply Wall St.
11:34AM  Allergan says revenue from aesthetics unit may double by 2025 Reuters
10:31AM  [$$] Allergan Acquires Neurotoxins Startup Bonti The Wall Street Journal
09:30AM  Is Allergan (AGN) a Great Stock for Value Investors? Zacks
09:15AM  Allergan to Acquire Bonti Adding New Neurotoxin Programs to Medical Aesthetics Pipeline PR Newswire
Sep-12-18 12:00PM  Why Bausch Health Companies Inc. Stock Is Booming Today Motley Fool
07:30AM  Allergan Unveils Spotlyte, A First-In-Category Digital Hub Designed To Educate Consumers About Medical Aesthetic Treatments PR Newswire
Sep-10-18 08:00AM  Allergan to Host Medical Aesthetics Day Event on September 14, 2018 PR Newswire
Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. It operates through US Specialized Therapeutics, US General Medicine, and International segments. The company offers a portfolio of products for the central nervous system, eye care, medical aesthetics and dermatology, gastroenterology, women's health, urology, and anti-infective therapeutic categories. It also provides breast implants and tissue expanders; RM-131 (relamorelin), a peptide ghrelin agonist for the treatment of diabetic gastroparesis; ocular implants; and Kybella, a non-surgical treatment for submental fullness. In addition, the company develops therapies for non-alcoholic steatohepatitis and other liver diseases; treatments for neurodegenerative disorders, including Alzheimer's disease; small molecule therapeutics that target inflammatory and fibrotic diseases; and delivery system and botulinum toxin-based prescription products. It has collaboration, option, and license agreement with Lyndra, Inc.; strategic alliance and option agreement with Editas Medicine, Inc.; and licensing agreements with Assembly Biosciences, Inc. MedImmune, and Heptares Therapeutics, Ltd. The company was formerly known as Actavis plc and changed its name to Allergan plc in June 2015. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COUGHLIN CHRISTOPHER JDirectorSep 06Buy190.6410,0001,906,39416,431Sep 07 08:31 AM
Boccuzi Joseph HDirectorAug 30Buy190.59900171,5313,885Sep 04 05:06 PM
FREYMAN THOMAS CDirectorAug 30Buy190.691,100209,7592,658Sep 04 05:07 PM
Basgoz NesliDirectorAug 30Sale190.051,055200,5037,359Sep 04 05:08 PM
Basgoz NesliDirectorAug 10Option Exercise81.161,889153,3119,248Aug 14 05:32 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Option Exercise68.1121,2521,447,47440,154May 21 05:21 PM
Meury WilliamEVP & Chief Commercial OfficerMay 17Sale154.5924,4253,775,86115,729May 21 05:21 PM
Hilado Maria TeresaExecutive Vice PresidentMar 15Buy167.39895149,81426,530Mar 19 09:36 AM
WALSH MATTHEW MEVP, Chief Financial OfficerMar 08Buy153.961,000153,96025,416Mar 08 10:44 AM
SAUNDERS BRENT LChairman, President and CEOMar 08Buy152.533,300503,349180,931Mar 08 10:25 AM
Boccuzi Joseph HDirectorMar 05Buy143.42900129,0781,862Mar 09 04:31 PM
WALSH MATTHEW MEVP, Chief Financial OfficerFeb 21Buy160.942,000321,88024,416Feb 22 04:25 PM
Meury WilliamChief Commercial OfficerFeb 14Option Exercise63.1723,6131,491,73778,600Feb 16 05:10 PM
Meury WilliamChief Commercial OfficerFeb 14Sale160.6258,8799,457,36919,721Feb 16 05:10 PM
BODINE CHRIS WDirectorDec 07Buy164.773,030499,25317,098Dec 07 05:21 PM
SAUNDERS BRENT LChairman, President and CEODec 06Buy164.744,600757,794186,377Dec 06 12:31 PM
COUGHLIN CHRISTOPHER JDirectorDec 05Buy163.3010,0001,633,00014,446Dec 05 04:16 PM
Meury WilliamChief Commercial OfficerDec 01Option Exercise78.8811,807931,33668,828Dec 04 06:21 PM
Meury WilliamChief Commercial OfficerDec 01Sale173.8911,8072,053,11957,021Dec 04 06:21 PM